by JOY IRUNGU
Friday October 24, 2025
Health Cabinet Secretary Aden Duale, together with the German delegation.
Health Cabinet Secretary Aden Duale has welcomed a high-level delegation from the German Bundestag, led by Mechthild Heil, for discussions on strengthening Kenya-Germany health cooperation.
The delegation supports the Global Fund’s 8th Replenishment — a global framework driving the fight against HIV, tuberculosis, and malaria while advancing progress toward Sustainable Development Goal 3: ending the three diseases as public health threats.
advertisements
“Kenya’s health sector reforms under the Taifa Care Model, with a focus on the Social Health Authority, represent a transformative initiative scaling up access to quality healthcare nationwide,” Duale stated.He emphasized the government’s investment in digital health systems designed to promote transparency, efficiency, and accountability in service delivery.
The Cabinet Secretary further highlighted integration, coordination, and value for money as guiding principles in implementing health reforms, noting that the Global Fund’s priorities align closely with those of Gavi, PEPFAR, and national investments.
“These efforts aim to strengthen laboratory networks, disease surveillance, and digital innovations from the community to the referral level,” he said.
The discussions also extended to the Kenya Biovax Institute, focusing on equipment sharing, technology transfer, and capacity development. Duale praised German partners for their crucial role in accelerating local vaccine production and research — key drivers of Kenya’s health security and sustainability.
He affirmed that Kenya continues to meet its 20% co-financing requirement under Global Fund guidelines, committing USD 593.3 million under the Fifth Administration to sustain HIV, TB, malaria, and community health programs.
Duale reaffirmed the Ministry’s commitment to national and global health goals, citing Kenya’s progress in reducing new HIV infections and expanding access to life-saving antiretroviral therapy.
Present during the meeting were Principal Secretary Dr. Ouma Oluga, Director-General Dr. Patrick Amoth, KEMSA CEO Dr.